百瀬修二

モモセシュウジ | MOMOSE Shuji

所属機関・部署：
職名：教授
ホームページURL (1件)： https://smc-pathology.blogspot.com/p/welcome.html
競争的資金等の研究課題 (9件)：

全件表示

論文 (11件)：

Kana Sakamoto, Satoko Baba, Yuka Okumura, Shuji Momose, Sawako Ono, Akiko Tonooka, Ryo Ichinohasama, Emi Takakuwa, Hideki Nakasone, Koichi Ohshima, et al. Comparison And Development Of Immunohistochemical Diagnostic Criteria For Blastic Plasmacytoid Dendritic Cell Neoplasm. Modern Pathology. 2023. -. -
Rizq O, Mimura N, Oshima M, Momose S, Takayama N, Itokawa N, Koide S, Shibamiya A, Miyamoto-Nagai Y, Rizk M, et al. UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease. Leukemia. 2023. -. -. 1-13
Yamashita T, Higashi M, Sugiyama H, Morozumi M, Momose S, Tamaru JI. Cancer Antigen 125 Expression Enhances the Gemcitabine/Cisplatin-Resistant Tumor Microenvironment in Bladder Cancer. Am J Pathol. 2023. 193. 3. 350-361
Asami Nishikori, Midori Filiz Nishimura, Yoshito Nishimura, Fumio Otsuka, Kanna Maehama, Kumiko Ohsawa, Shuji Momose, Naoya Nakamura, Yasuharu Sato. Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease. International Journal of Molecular Sciences. 2022. 23. 18
Yoshito Nishimura, Asami Nishikori, Haruki Sawada, Torrey Czech, Yuki Otsuka, Midori Filiz Nishimura, Hiroki Mizuno, Naoki Sawa, Kumiko Ohsawa, Fumio Otsuka, et al. Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?. Journal of Clinical and Experimental Hematopathology. 2022. 28. 62. 99-105

書籍 (4件)：

講演・口頭発表等 (105件)：

リンパ腫の疾患概念:WHO分類第5版/ICC分類で何が変わるのか高悪性度B細胞リンパ腫とその鑑別疾患の病理診断
(第63回日本リンパ網内系学会学術集会 2023)
Aggressive B-cell lymphoma の組織所見および細胞所見
(第64回日本臨床細胞学会総会春期大会 2023)
Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan
(64TH ASH ANNUAL MEETING 2022)
Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)
(2022)
CD20 陽性濾胞 T 細胞リンパ腫の3例
(第67回日本病理学会秋期特別総会 2021)

学位 (1件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

百瀬 修二